Daewoong Co., Ltd. (KRX:003090)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,800
-150 (-0.65%)
Last updated: Apr 29, 2026, 1:40 PM KST
16.33%
Market Cap 938.44B
Revenue (ttm) 2.07T
Net Income (ttm) 175.06B
Shares Out 40.89M
EPS (ttm) 4,280.00
PE Ratio 5.36
Forward PE n/a
Dividend 200.00 (0.86%)
Ex-Dividend Date Dec 29, 2025
Volume 29,983
Average Volume 73,471
Open 23,200
Previous Close 22,950
Day's Range 22,800 - 23,200
52-Week Range 18,870 - 30,600
Beta 0.53
RSI 46.19
Earnings Date May 15, 2026

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, So... [Read more]

Sector Healthcare
Founded 1945
Employees 379
Stock Exchange Korea Stock Exchange
Ticker Symbol 003090
Full Company Profile

Financial Performance

In 2025, Daewoong's revenue was 2.07 trillion, an increase of 6.79% compared to the previous year's 1.94 trillion. Earnings were 175.06 billion, an increase of 202.43%.

Financial Statements

News

AEON Biopharma Completes BPD Type 2a Meeting With FDA

(RTTNews) - AEON Biopharma, Inc. (AEON), a biopharmaceutical company that develops ABP-450 as a biosimilar to BOTOX, reported that it held a BPD Type 2a meeting with the FDA in addition to the closure...

3 months ago - Nasdaq